Hydrobromic Acid Market Analysis

  • Report ID: 5737
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Hydrobromic Acid Market Analysis

Product (Hbr 48%, Hbr 62%)

The Hbr 48% segment is expected to hold 65% share of the global hydrobromic acid market by 2037. The reason behind this segment’s dominance is the rising investment in the pharmaceutical industry and Hbr 48% is immensely used in making medications. The industry's upcoming course is hopeful, with the pharmaceutical components market expected to touch around USD 130 billion by the end of 2030. Simultaneously, the international pharmaceutical components market is projected to exceed the USD 1 trillion mark by the end of 2024. The pharma industry is incorporated into some major multinational organizations. Depending on prescription drug sales, U.S. organization Pfizer has been among the global foremost pharmaceutical organizations for many years. The organization, which has its international headquarters in New York City, produced a total profit of over 100 billion U.S. dollars in 2022. A lot of the foremost pharma organizations come from the United States, and, thus, it is no astonishment that the country has the biggest national health and pharmaceutical market globally.

Application (Food & Beverage, Pharmaceutical, Agricultural, Chemical)

The chemical segment in the hydrobromic acid market is projected to account for 40% of the revenue share by 2037. This supremacy of the segment will be noticed due to the wide expansion of the chemical industry across the world. In 2023, a calculated USD 2.8 trillion was spent internationally on energy, with over 60% invested in clean energy technology, like sustainable resources, EVs, and battery storage. Part of this has been in answer to the regulation of the United States that is assisting to encourage private-sector investment. For instance, in the year after the CHIPS Act was approved into law, the private sector declared USD 166 billion in spending on semiconductor plants, and in the year since the IRA was approved into law, the private sector declared roughly USD 88 billion in clean energy manufacturing.

Our In-Depth Analysis of The Global Market Includes the Following Segments:

          Type

  • Organic Bromides
  • Inorganic Bromides

          Product

  • Hbr 48%
  • Hbr 62%

          Application

  • Food & Beverage
  • Pharmaceutical
  • Agricultural
  • Chemical

          End-Use Industry

  • Food Industry
  • Pharmaceutical Industry
  • Chemical Industry
  • Textile Industry
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 5737
  • Published Date: Oct 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hydrobromic acid is assessed at USD 909.36 million.

Hydrobromic Acid Market size was over USD 857.24 million in 2024 and is expected to reach USD 2.22 billion by the end of 2037, witnessing around 7.6% CAGR during the forecast period i.e., between 2025-2037. The increasing consumption of electricity across the world will drive the market growth.

North America industry is likely to dominate majority revenue share of 42% by 2037, due to regions pharmaceutical companies increasing investment in making more potent drugs.

The major players in the market are Manac Inc., Chemieorganic Chemicals, Merck KGaA, BASF, ERCO Worldwide, Haiwang Chemical, BLUESTAR ENTERPRISES, Alpha Chemika, Jordan Bromine, Kemira, Kaname Chemicals Co., Ltd., JFE Chemical Corporation, Shoko Co., Ltd., Toagosei Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample